Diana McDermott
Internal Medicine · Chalmette, LANPI 1174738157
Payments from drug & device makers
Across 64 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$146
- Lilly USA, LLC$140
- Amgen$133
- Actelion Pharmaceuticals US, Inc.$125
- Novo Nordisk$110
- Pfizer$92
- plus $439 from 14 others
What the payments were for
- Food & beverage$1,184100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 8 | $146 |
| Lilly USA, LLC | 9 | $140 |
| Amgen | 8 | $133 |
| Actelion Pharmaceuticals US, Inc. | 1 | $125 |
| Novo Nordisk | 7 | $110 |
| Pfizer | 6 | $92 |
| Abbott | 4 | $77 |
| Corcept Therapeutics | 2 | $48 |
| Gilead | 3 | $46 |
| GSK | 3 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $38 |
| AstraZeneca | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
| Exact Sciences | 1 | $21 |
| Viiv Healthcare Company | 1 | $20 |
| Alkermes, Inc. | 1 | $19 |
| Braeburn Inc. | 1 | $17 |
| Organon | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
| Cranial Technologies, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,184 in reported general payments places this provider in the 65th percentile of 1,528 internal medicine providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 84 | $128,764 |
| JardianceEmpagliflozin | 60 | $98,625 |
| JanuviaSitagliptin Phosphate | 46 | $53,088 |
| JanumetSitagliptin Phos/Metformin Hcl | 32 | $49,876 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 41 | $47,572 |
| TrulicityDulaglutide | 35 | $38,597 |
| FarxigaDapagliflozin Propanediol | 20 | $31,918 |
| LinzessLinaclotide | 27 | $24,399 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 17 | $20,657 |
| SynjardyEmpagliflozin/Metformin Hcl | 11 | $20,573 |
| XareltoRivaroxaban | 12 | $19,230 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 22 | $17,377 |
| EliquisApixaban | 12 | $17,243 |
| SymbicortBudesonide/Formoterol Fumarate | 26 | $10,444 |
| Spiriva RespimatTiotropium Bromide | 12 | $8,609 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $110 | $128,76484 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $45 | $64,94963 claims |
| AstraZenecaFarxiga, Symbicort | $33 | $42,36146 claims |
| Lilly USA, LLCTrulicity | $140 | $38,59735 claims |
| AbbVieLinzess | $146 | $24,39927 claims |
| PfizerEliquis | $92 | $17,24312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,528 internal medicine providers in Louisiana.
Other internal medicine in Chalmette
- William SmithNew Orleans$50.5M
- Robert JeanfreauMetairie$13.4M
- Katherine PearceBaton Rouge$12M
- Ernest ThompsonBaker$2.1M
- Brian LewisNew Orleans$2M
- Otis BarnumNatchitoches$1.8M
- Satinder SainiCrowley$1.8M
- Randall MillerEunice$1.2M
- Donna RyanBaton Rouge$991K
- Steven DeitelzweigNew Orleans$939K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.